The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of the combination of entinostat with capecitabine in high-risk breast cancer after neoadjuvant therapy.
 
Clare Humphrey
No Relationships to Disclose
 
Trish Ann Millard
No Relationships to Disclose
 
Christiana Brenin
Consulting or Advisory Role - Theraclion (I)
Research Funding - Theraclion (I)
Travel, Accommodations, Expenses - Theraclion (I)
 
Ajay Dhakal
Honoraria - AstraZeneca; Gilead Sciences; OncLive/MJH Life Sciences; OncLive/MJH Life Sciences; WebMD/Medscape
Research Funding - Celcuity; Puma Biotechnology
 
Carla Isadora Falkson
Honoraria - Curio Science
Consulting or Advisory Role - Agendia; bioTheranostics
Speakers' Bureau - OncLive/MJH Life Sciences
Research Funding - Lilly (Inst); Oncolytics (Inst); QuantumLeap Health (Inst)
 
Gina R. Petroni
Research Funding - Merck
 
Nolan Wages
Research Funding - Abbvie (Inst)
 
Patrick Michael Dillon
Research Funding - Daichi Sankyo (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Tolero Pharmaceuticals (Inst)